| Target | CD52 |
|---|
| Application | FA, FC, IHC FF, IHC FFPE |
|---|
| Clonality | Monoclonal |
|---|
| Conjugate | DyLight® 488 |
|---|
| Isotype | Human IgG1κ |
|---|
| Immunogen | Human lymphocytes. |
|---|
| Species Reactivity | Human, Cynomolgus Monkey, Rhesus Monkey |
|---|
| Formulation | This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. |
|---|
| Research Area | Cancer, Immunology |
|---|
| Description/Background | Clone Campath-1H is a monoclonal antibody that specifically binds to CD52, a protein present on the surface of mature lymphocytes. However, this protein is not present on the stem cells that generated these lymphocytes. Alemtuzumab is targets and destroys mature lymphocytes containing CD-52, and is used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis. Anti-Human CD52 (Alemtuzumab) utilizes the same variable regions from the therapeutic antibody Alemtuzumab making it ideal for research projects. |
|---|
| Storage Temperature | This DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze. |
|---|
| Protocols | FA, FC, IHC FF, IHC FFPE |
|---|
| Clone Number | Campath-1H |
|---|
| Concentration | 0.2 mg/ml |
|---|
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
|---|
